StockWatch
·

Data Patterns (India) Ltd Q2 FY27 Results

DATAPATTNSQ2 FY27 Results
Filing
Result:Weak· Market: Down#Base effect

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValue (₹ Cr)
Revenue133.25
Total Income141.41
Expenditure112.02
PBT29.39
Net Profit21.82
OPM23.53%
NPM15.43%
EPS3.86
View full financials

Defence-sector revenue and adjusted PAT both fell ~56% YoY against an unusually strong year-ago quarter, a clear core-metric decline even though OPM/NPM margins held broadly flat.

DATA PATTERNS · Q2 FY27 · THE VERDICT

₹133 Crore Revenue, ₹2,700 Crore Order Book — Why the Math Doesn't Add Up Yet

Data Patterns reported a 57% YoY revenue collapse to ₹133 Crore, yet management reaffirmed 20–25% FY27 growth guidance. The call reveals why: execution delays on government approvals have stranded a strong order book. The question is whether this is temporary lumpiness or structural risk.

16 Nov 2026 · 6 min read
Q2 Revenue

₹133.3 Cr

–56.7% YoY from ₹306 Cr

Order book + negotiated

₹3.6+ Cr

₹2,698 Cr + ₹956 Cr awaiting formal receipt

PAT

₹21.8 Cr

–55.6% YoY; NPM 15.4%

Cash & bank

>₹500 Cr

Supports ₹150–200 Cr capex plan

The core tension: visibility without execution

The quarter's headline is unambiguous: revenue ₹133.3 Crore, down 57% year-on-year from ₹306 Crore in Q2 FY26. PAT fell in tandem to ₹21.8 Crore (–55.6% YoY), with operating margin at 23.5%, below the 35–40% EBITDA range management reaffirmed on this call. But alongside that collapse sits an order book of ₹2,698 Crore (as of 30-Sep-2026), plus another ₹956 Crore in negotiated contracts awaiting formal government receipt. That's ₹3.6+ Crore of visibility—enough to cover 27 quarters at the current revenue run rate. The gap between that order book and this quarter's ₹133 Crore execution is the real story.

Management's claims: what holds up

Earnings call claims vs. what the numbers show

Order inflows in H1 FY27 reached ₹1,046 Cr, including ₹929 Cr in Q2

Confirmed. Q2 inflows were strong, dominated by defence radar and EW orders. Signals growing customer confidence.

Supported

Reaffirming 20–25% FY27 revenue growth and 35–40% EBITDA margins

H1 YoY revenue down 56.7% (₹133 Cr Q2 + ₹116 Cr Q1). To hit 20% FY27 growth, H2 must grow ~38% YoY. Achievable only if large orders convert immediately. OPM 23.5% contradicts margin guidance.

Overstated

Order book ₹2,698 Cr provides healthy visibility

Order book is real, but ₹956 Cr (26% of the total) remains negotiated and awaiting formal government receipt. CFO stated delays are due to 'internal processes… different approval processes.' Execution timing uncertain.

Partial

No cancellation risk on government orders

Management confident—all are Central Govt funded tenders. But delays evident (Q2 inflows haven't yet translated to Q2 revenue). Timing risk is real, even if cancellation risk is low.

Supported (but timing risk high)

What changed on this call

  • Order inflow acceleration: H1 FY27 ₹1,046 Cr vs. ₹167 Cr in Q1 FY26 (comparable quarter)—4x faster.

  • ST Advanced Composites 100% acquisition (Sep 2026) to strengthen composite design and manufacturing for radars.

  • Revenue execution timing slippage: Q2 FY27 ₹133 Cr vs. ₹306 Cr Q2 FY26, largest miss in at least two years.

  • Capex plan expanded: ₹150–200 Cr baseline over 2 years, plus additional investment (>₹150 Cr) planned post-Board approval for satellite and new manufacturing infrastructure.

  • New product roadmap visible but timeline risk: satellite launch 3–4 years away; counter-drone demo-ready in 1–2 months; BrahMos seeker still in qualification; Tejas Mk2 under negotiation.

The bull-bear ledger

  • Order book ₹3.6+ Crore (including negotiated) provides tangible multi-year visibility in a defence hardware business.

  • Defence indigenization tailwind (Make in India, Make II) structural—DRDO and MoD emphasizing domestic vendors over imports.

  • Cash position >₹500 Cr supports capex intensity (₹150–200 Cr over 2 years) without external financing.

  • Engineering capability expanding (1,100+ engineers, active recruitment, ISRO partnership for satellite program).

  • Q2 revenue collapse (–57% YoY) contradicts FY27 guidance (20–25% growth); requires unlikely 38% H2 ramp.

  • Operating margin 23.5%, well below 35–40% guidance range; heavy R&D and capex drag near-term profitability.

  • Government approval bottleneck evident: ₹956 Cr negotiated orders stuck in 'internal processes'; CFO acknowledged delays.

  • New products are 3–4 years out (satellite) or early-stage (counter-drone, Tejas Mk2); near-term revenue upside limited.

  • Customer concentration on DRDO, PSUs (Bharat Electronics, HAL); government budget cycles and approval processes uncontrollable.

  • Export market nascent; PAR radars in progress (delivery Q1 FY28 expected) but revenue timing uncertain.

Risks, ranked by how much they should concern a holder

Order execution timing slippage

High

₹956 Cr negotiated orders are stuck waiting for government internal approvals. CFO explicitly framed this as endemic ('different approval processes'). Q2 order inflows (₹929 Cr) haven't yet converted to revenue. If delays extend into Q3/Q4, FY27 guidance (20–25% growth) becomes unachievable.

FY27 growth guidance at risk

High

H1 YoY revenue declined 56.7%. To achieve 20% FY27 growth, H2 must grow ~38% YoY—a dramatic ramp from 27% underperformance in H1. Analysts pressed management on feasibility; responses deflected to 'lumpy business' without owning execution gaps.

New product revenue still 3–4 years out

High

Satellite program, anti-drones, Tejas Mk2, BrahMos seeker are all early-stage or in qualification. None contribute to revenue in the next 12–18 months. Near-term growth depends entirely on order-book conversion from existing government contracts.

Government customer concentration and approval bottleneck

Medium

DRDO, HAL, Bharat Electronics dominate the customer base. Budget cycles, tender timelines, and internal approval processes are uncontrollable. Private sector expansion is nascent. Export market (PAR radars) is early-stage.

Capex intensity relative to cash buffer

Medium

₹150–200 Cr capex over 2 years on ~₹500 Cr cash leaves limited margin for operational shocks. Additional investment (>₹150 Cr) planned post-Board approval further tightens liquidity. Working capital cycle elongating due to government payment delays.

Margin compression from R&D and facility capex

Medium

OPM 23.5% is 11–16pp below the 35–40% EBITDA guidance. Heavy R&D on satellite, counter-drone, and new facilities will continue to drag margins in the near term. No path to guidance-level margins visible in near-term.

How the street is positioned

The stock closed at ₹4,190 on result day (16-Nov-2026), trading in a neutral trend. At this price, it sits 16.18% below its all-time high of ₹4,999, but +96.62% off the 52-week low. RSI at 54.4 signals no overbought or oversold condition—the market is still forming a consensus. Institutional positioning has shifted: FII trimmed from 12.50% (Q1 FY27) to 11.34% (Q2 FY27), a drop of 1.16pp. DII added 1.03pp to 13.01%. The divergence is telling: foreign investors are stepping back ahead of the guidance-vs-execution debate; domestic institutions are buying selectively at lower levels. Recent bulk activity shows Graviton Research Capital selling ~4 lakh shares at ₹3,943 and buying ~4 lakh at ₹3,944 on 9-Nov-2026—opportunistic trading near the 52-week moving average, not a structural vote of confidence. Volume is increasing, but price hasn't broken through previous resistance. The market's own verdict: wait for clarity on H2 order execution before committing fresh capital.

The debate

What to watch next

  • 1 · Negotiated order closure timeline (expected 1–2 months)

    Management guided that ₹956 Cr in negotiated orders should close formally by Nov-Dec 2026. This is the binary catalyst. If closures slip beyond that window, guidance miss risk rises sharply.

  • 2 · Q3 FY27 revenue run-rate and order-to-execution conversion

    By Q3 earnings (expected Feb 2027), the street will see whether H2 acceleration is real. A ₹160–180 Cr Q3 run-rate (vs. ₹133 Cr Q2) would signal order-to-revenue conversion is normalizing. Below ₹150 Cr suggests execution delays persist.

  • 3 · Operating margin trend and capex impact

    OPM at 23.5% is below guidance. Watch whether margins recover toward 30%+ as order delivery accelerates, or if new facility capex and R&D spending (satellite, counter-drones) continue to compress profitability in Q3–Q4.

  • 4 · FII/DII flows and institutional consensus

    FII trimmed 1.16pp this quarter while DII added. If FII continues to exit heading into Q3 earnings (before H2 guidance clarity), that's a risk signal. DII adds suggest some domestic institutions see value at current levels, but they may be early.

The number to track

H2 FY27 order-to-revenue conversion rate. If Data Patterns can convert ₹800+ Crore of its ₹1.7 Crore order book into H2 (Jan–Mar 2027) revenue, the ₹20–25% FY27 growth guidance holds and the stock has room to re-rate above ₹4,500. If H2 conversion stays below ₹150 Cr per month (implying ₹300 Cr or less for the half), the year will miss guidance materially, and the stock will drift back toward ₹3,500–₹3,800 as the market reprices execution risk. The order book is real—the question is when it becomes revenue.

Data Patterns is not a broken company. The order book is visible, the defence indigenization tailwind is structural, and the engineering talent is real. But Q2's 57% revenue collapse and the stranded ₹956 Crore in negotiated orders expose a hard truth: this is a government-paced business, and government approvals are not on management's timeline. Reaffirming 20–25% FY27 growth while reporting a 56.7% H1 YoY decline is a bet on compressed execution in H2—achievable but risky. For holders, this is a 'prove it next quarter' moment. For new buyers, waiting for Q3 earnings clarity (Feb 2027) after seeing whether the negotiated orders close and H2 execution accelerates is the prudent path. The stock's retreat from ATH is fair. The real price discovery happens when order-to-revenue conversion becomes visible.

Informational and educational content only. Not investment advice.